<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-title-group><journal-title>BMC Musculoskeletal Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2474-10-142</article-id><article-id pub-id-type="pmid">19925654</article-id><article-id pub-id-type="doi">10.1186/1471-2474-10-142</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research article</subject></subj-group></article-categories><title-group><article-title>The expression of <italic>Gli3</italic>, regulated by HOXD13, may play a role in idiopathic congenital talipes equinovarus</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Cao</surname><given-names>DongHua</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>dhcao427@sina.com</email></contrib><contrib contrib-type="author" corresp="yes" id="A2"><name><surname>Jin</surname><given-names>ChunLian</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>chunlianjin@126.com</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Ren</surname><given-names>MeiHong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>renmeihong@163.com</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Lin</surname><given-names>ChangKun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cklin@mail.cmu.edu.cn</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Zhang</surname><given-names>Xuan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zhangxuan1997@163.com</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Zhao</surname><given-names>Ning</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ningzhao78@hotmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Medical Genetics, China Medical University, Shenyang, 110001, PR China</aff><aff id="I2"><label>2</label>Department of Test, No.202 hospital of People's Liberation Army, Shenyang, 110003, PR China</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>11</month><year>2009</year></pub-date><volume>10</volume><fpage>142</fpage><lpage>142</lpage><history><date date-type="received"><day>1</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>19</day><month>11</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2009 Cao et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Cao et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://www.biomedcentral.com/1471-2474/10/142"/><abstract><sec><title>Background</title><p>Idiopathic congenital talipes equinovarus (ICTEV) is a congenital limb deformity. Based on extended transmission disequilibrium testing, <italic>Gli-Kruppel family member 3 </italic>(<italic>Gli3</italic>) has been identified as a candidate gene for ICTEV. Here, we verify the role of <italic>Gli3 </italic>in ICTEV development.</p></sec><sec><title>Methods</title><p>Using the rat ICTEV model, we analyzed the differences in <italic>Gli3 </italic>expression levels between model rats and normal control rats. We used luciferase reporter gene assays and ChIP/EMSA assays to analyze the regulatory elements of <italic>Gli3</italic>.</p></sec><sec><title>Results</title><p><italic>Gli3 </italic>showed higher expression levels in ICTEV model rats compared to controls (P &#x0003c; 0.05). We identified repressor and activator regions in the rat <italic>Gli3 </italic>promoter. The <italic>Gli3 </italic>promoter also contains two putative Hoxd13 binding sites. Using EMSA, the Hoxd13 binding site 2 was found to directly interact with Hoxd13 <italic>in vitro</italic>. ChIP assays of the Hoxd13-<italic>Gli3 </italic>promoter complex from a developing limb confirmed that endogenous Hoxd13 interacts with this region <italic>in vivo</italic>.</p></sec><sec><title>Conclusion</title><p>Our findings suggest that <italic>HoxD13 </italic>directly interacts with the promoter of <italic>Gli3</italic>. The increase of <italic>Gli3 </italic>expression in ICTEV model animal might result from the low expression of <italic>HoxD13</italic>.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Idiopathic congenital talipes equinovarus (ICTEV) is a congenital limb deformity that affects 0.3-7% of live births worldwide [<xref ref-type="bibr" rid="B1">1</xref>]. It is defined by fixation of the foot in cavus, adductus, varus and equinus (inclined inwards, axially rotated outwards and pointing downwards) with related soft tissue abnormalities [<xref ref-type="bibr" rid="B2">2</xref>]. The mechanism underlying the development of ICTEV remains unclear, and neurological, muscular, bony, connective tissue and vascular mechanisms have all been proposed as contributing factors [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B5">5</xref>]. Although some studies have suggested that both genetic and environmental factors lead to ICTEV, twin studies, ethnic studies and pedigree analyses suggest a genetic basis for the condition [<xref ref-type="bibr" rid="B6">6</xref>]. Furthermore, studies have suggested that a significant ICTEV risk can be attributed to unknown disorder-causing genes [<xref ref-type="bibr" rid="B1">1</xref>]. Overall, little is known about the pathogenesis of human ICTEV.</p><p>Many candidate genes for this disorder have been proposed because the molecular and cellular components of vertebrate limb bud development are well known. Specialized regions of the developing limb bud, such as the zone of polarizing activity (ZPA), the apical ectodermal ridge (AER) and the non-ridge ectoderm, direct and coordinate the development of the limb bud along the anterior-posterior (AP), dorsal-ventral (DV) and proximal-distal (PD) axes in a pattern conserved for tetrapods [<xref ref-type="bibr" rid="B7">7</xref>]. Distal limb development along the AP (thumb to little finger) axis is governed primarily by the ZPA. The major signaling molecule with polarizing potential in the ZPA is Sonic hedgehog (Shh) [<xref ref-type="bibr" rid="B8">8</xref>], which plays a central role in pattern formation in the embryo [<xref ref-type="bibr" rid="B9">9</xref>] and is a key signal in establishing different digit fates along the AP axis of the vertebrate limb bud [<xref ref-type="bibr" rid="B10">10</xref>]. In <italic>Drosophila</italic>, hedgehog (Hh) signaling is mediated by the Cubitus interruptus (Ci) protein, a zinc finger transcription factor. In birds and mammals, Ci homologs constitute the three member <italic>Gli </italic>family (<italic>Gli1, Gli2, and Gli3</italic>). All three <italic>Gli </italic>genes are expressed in the developing limb, but only <italic>Gli3</italic>, a direct intracellular mediator of Shh [<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>], is necessary for limb patterning [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. With a C-terminal repressor region and an N-terminal activator region, <italic>Gli3 </italic>is a bipotential transcription factor that can activate or repress some of the same target genes [<xref ref-type="bibr" rid="B16">16</xref>]. During vertebrate limb development, Shh signaling prevents the processing of the full-length Gli3 (Gli3-190) to a short form (Gli3-83) that functions as a strong repressor. In both mouse and chick limb buds, the repressor form of Gli3 is present in an anterior-posterior gradient with the highest levels in the anterior part of the limb bud where Shh signaling is at its lowest levels. The genetic data of the Shh, Gli3 and double-compound mutants indicate that the phenotype in the absence of Shh is caused by an excess in the Gli3R form that suppresses gene expression, cell survival and distal progression of limb bud development. Gli3 and Shh reciprocally restrict each other to control the normal limb morphogenesis [<xref ref-type="bibr" rid="B17">17</xref>].</p><p>A third family of transcription factors involved in limb development is the <italic>HOX </italic>family, which is evolutionarily conserved and plays a fundamental role in patterning the AP axis of developing embryos. Each HOX protein mediates cellular events during limb morphogenesis [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. The physical position of the <italic>Hox </italic>gene within each cluster corresponds closely to their temporal and spatial expression patterns during development. Thus, genes at the 3' end of the clusters, such as <italic>HOXD1</italic>, are expressed early in the anterior and proximal regions, whereas genes at the 5' end, such as <italic>HOXD13</italic>, are expressed later in posterior and distal regions [<xref ref-type="bibr" rid="B20">20</xref>]. In early limb bud development, the <italic>Gli3 </italic>anterior expression overlaps the <italic>HoxD </italic>posterior expression, indicating that a genetic interaction between a 5' HoxD member and <italic>Gli3 </italic>regulates digit formation [<xref ref-type="bibr" rid="B21">21</xref>]. Biochemical and transfection analyses provide support for the physical interaction of the 5' HoxD protein and Gli3 protein via the homeodomain [<xref ref-type="bibr" rid="B21">21</xref>]. This interaction can convert the truncated Gli3 repressor form into an activator of its target promoters [<xref ref-type="bibr" rid="B21">21</xref>].</p><p>Most <italic>Gli3 </italic>research focuses on digit abnormalities and deformities. <italic>Gli3 </italic>mutations cause limb development disorders, such as Greig cephalopolysyndactyly syndrome (GCPS) [<xref ref-type="bibr" rid="B22">22</xref>], Pallister-Hall syndrome (PHS) [<xref ref-type="bibr" rid="B23">23</xref>], postaxial polydactyly type A (PAP-A) [<xref ref-type="bibr" rid="B24">24</xref>] and preaxial polydactyly type IV [<xref ref-type="bibr" rid="B25">25</xref>]. Association analyses suggest that <italic>Gli3 </italic>and <italic>HoxD13 </italic>are associated with ICTEV [<xref ref-type="bibr" rid="B26">26</xref>-<xref ref-type="bibr" rid="B28">28</xref>]. To confirm a role for <italic>Gli3 </italic>in ICTEV, we analyzed <italic>Gli3 </italic>expression in ICTEV model rat embryos. To understand how a change in the expression of <italic>Gli3 </italic>affects ICTEV, we investigated the interaction between <italic>Gli3 </italic>and HoxD13.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>ICTEV patients and normal controls</title><p>Flexor hallucis longus was from 20 ICTEV patients (13 men and 7 women) aged 4-12 years (mean 6.7 years) and peripheral blood was from 84 ICTEV patients (50 men and 34 women) aged 3-12 years (mean 6.2 years). All patients were recruited from the Department of Pediatric Orthopedic Surgery, Second Affiliated Hospital of China Medical University. Informed consent was obtained from the patients and the study was approved by the China Medical University Ethics Committee. The probands showed the typical ICTEV phenotype (a fixation of the foot in adduction, supination and varus). Flexor hallucis longus and lung tissue were from nine normal cadavers (5 men and 4 women) aged 5-11 years (mean 7.5 years) as controls.</p></sec><sec><title>A rat ICTEV model</title><p>Forty pregnant Wistar rats were obtained from the experimental animal center of our university. The ICTEV phenotype in rat embryos was induced by administration of 135 mg/kg all-trans-retinoic acid (ATRA) on gestation day 10 (GD10), as previously described [<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. All studies were performed with the approval of the experimental animal committee at our university (SCXK 2008-0005).</p></sec><sec><title>RNA isolation and expression analysis</title><p>The <italic>Gli3 </italic>gene is expressed as an 8.5 kb mRNA in tissues such as the postnatal testis, myometrium, placenta and lung [<xref ref-type="bibr" rid="B31">31</xref>]. We investigated whether the gene was also expressed in the hindlimb. RNA was therefore extracted from the flexor hallucis longus of ICTEV patients and normal controls using a Tissue RNA kit (Tiangen, China) according to the manufacturer's protocol. RNA was also extracted from lung tissues of normal cadavers as a positive control. Using a reverse transcription kit (Promega, USA) according to the manufacturer's instructions, cDNA was generated. For <italic>Gli3</italic>, the forward and reverse primers were 5'-TTT TCC AAC ACA GAG GCC TAT TC-3' and 5'-ATC TTG GAC CTC TTG TTG TGC AT-3', respectively. Human &#x003b2;-actin forward and reverse primers were 5'-TCA CCC ACA CTG TGC CCA TCT ACG A-3' and 5'-CAG CGG AAC CGC TCA TTG CCA ATG G-3', respectively. PCR reactions contained 40 ng cDNA, 1.2 mM MgCl<sub>2</sub>, 20 mM dNTPs, 320 nM of each primer and 2U Taq polymerase in a 25 &#x003bc;l total volume. PCR reactions had an initial denaturing step at 94&#x000b0;C for 5 minutes, followed by 35 cycles of denaturing at 94&#x000b0;C for 45 sec, annealing at 58&#x000b0;C for 45 sec and extension at 72&#x000b0;C for 60 sec, and ended with a final extension at 72&#x000b0;C for 10 min.</p></sec><sec><title><italic>Gli3 </italic>expression in ICTEV rat models and normal control rats</title><p>Real-time PCR (RT-PCR) was performed to evaluate differences in RNA expression levels. The ICTEV model rats were dissected at GD15, GD17, GD19 and GD21. Five embryos with clubfoot were selected and the hindlimbs of the embryos were stored at -70&#x000b0;C. We also dissected control rats at GD15, GD17, GD19 and GD21 and five embryos were selected and their hindlimbs were similarly stored. RNA was extracted from the hindlimbs using a Tissue RNA kit (Tiangen, China) and cDNA was synthesized using a reverse transcription kit (Promega, USA) according to the manufacturer's instructions. Real-time PCR amplification was performed in a 25 &#x003bc;l reaction mixture, which included 12.5 &#x003bc;l SYBR Premix Ex Taq, 9.5 &#x003bc;l deionized water, 0.5 &#x003bc;l (initial concentration 10 &#x003bc;M) of each primer and 2 &#x003bc;l cDNA, according to the manufacturer's instructions (Takara Biotechnology). Amplification was performed by one round of pre-denaturation at 95&#x000b0;C for 10 s, a step-cycle mode of 40 rounds of denaturation at 95&#x000b0;C for 5 s and an annealing and extension step at 58&#x000b0;C for 20 s. The primers used for <italic>Gli3 </italic>were: forward: 5'-TTT TCC AAC ACA GAG GCC TAT TC-3' and reverse: 5'-ATG CAC AAC AAG AGG TCC AAG AT-3'. The primers of &#x003b2;-actin were: forward: 5'-TCC TTC CTG GGT ATG GAA TC- 3' and reverse: 5'-GCA CTG TGT TGG CAT AGA GG-3'.</p><p>To evaluate Gli3 protein expression level, we performed western blot analyses. Cytoplasmic protein was extracted from the embryonic hindlimbs of five rats presenting with clubfoot and normal control rat embryonic hindlimbs at GD15 and GD17 using a cytoplasmic and nuclear protein extract kit (Activ Motif, USA) according to the manufacturer's instructions. Protein concentration was determined spectrophotometrically (Unico, USA) at 280 nm[<xref ref-type="bibr" rid="B32">32</xref>]. Sample buffer (Beyotime, China) was added to the cytoplasmic protein and the solution was loaded onto a 6% polyacrylamide gel. Following protein separation, the polyacrylamide gel was electro-blotted onto a PVDF membrane (Millipore, MA, USA). Non-specific binding sites were blocked by soaking the membrane in a 3% BSA (Sigma, Poole, Dorset, UK) in TBST buffer (20 mM Tris-buffered saline, 0.047% Tween at pH 7.4) blocking solution overnight at 4&#x000b0;C. The membrane was incubated for 3 hours with rabbit anti-human Gli3 polyclonal antibody (Santa Cruz, USA, 1:50 dilution) at room temperature and washed for 40 min in TBST buffer. The membrane was then incubated for 2 hours at room temperature with a goat anti-rabbit IgG horseradish peroxidase-conjugated antibody (Antibodies Incorporated, USA. 1:4000 dilution). Protein bands were visualized using modified enhanced chemiluminescence (Tiangen, China).</p><p>To determine differences in Gli3 levels and localization, we used immunohistochemistry assays. The ICTEV model rats and control rats were dissected at GD19. We selected five embryos presenting with clubfoot from the ICTEV rats and five normal embryos from normal control rats. The hindlimbs of the embryos were embedded in paraffin and fixed in 4% paraformaldehyde overnight at 4&#x000b0;C. The tissues were sectioned into 4-&#x003bc;m slices and labeled with Gli3 antibody (Santa Cruz, USA, 1:50 dilution). The normal control hindlimbs were labeled with Phosphate buffered saline as negative controls. A standard immunohistochemistry protocol was used (Maxim Biotech, Inc., USA).</p></sec><sec><title><italic>Gli3 </italic>mutation analysis</title><p>Genomic DNA was extracted from 84 fresh blood samples obtained from the ICTEV patients using a Blood DNA kit (Tiangen, China) according to the manufacturer's protocol. A previous study investigated mutations in <italic>Gli3 </italic>exons 9, 10, 11 and 12 [<xref ref-type="bibr" rid="B26">26</xref>]. We therefore designed primers (shown in Table <xref ref-type="table" rid="T1">1</xref>) to amplify the remaining <italic>Gli3 </italic>exons 1-8, 13 and 14 and the 5' flanking sequence. Mutations in <italic>Gli3 </italic>were detected by denaturing gradient gel electrophoresis (DGGE), a sensitive method to separate alleles based on differences in melting behavior [<xref ref-type="bibr" rid="B33">33</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><italic>Gli3 </italic>primers for DGGE</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="left">Primer sequence</th><th align="left">Annealing Temp (&#x000b0;C)</th><th align="left">Product size (bp)</th></tr></thead><tbody><tr><td align="right">Promoter 1 F</td><td align="left">*AGCTTGCAGTTCCCTTGC</td><td align="left">60</td><td align="left">684</td></tr><tr><td align="right">R</td><td align="left">GTCCGACAATTTCTAACATCGA</td><td/><td/></tr><tr><td align="right">Promoter 2 F</td><td align="left">*GCCTTCGATGTTAGAAATTGTCG</td><td align="left">62</td><td align="left">668</td></tr><tr><td align="right">R</td><td align="left">TGGGCTGCTGGTAATCCCTGTGC</td><td/><td/></tr><tr><td align="right">Exon 1 F</td><td align="left">*TTTTGGAAAGTTGATGGCTCT</td><td align="left">60</td><td align="left">229</td></tr><tr><td align="right">R</td><td align="left"><monospace>GGCTGCTGGTAATCCCTGT</monospace></td><td/><td/></tr><tr><td align="right">Exon 2 F</td><td align="left"><monospace>*AATTGCTCCTTAAAGTAGTT</monospace></td><td align="left">60</td><td align="left">335</td></tr><tr><td align="right">R</td><td align="left"><monospace>CATAGCTCCTGAACAAGTG</monospace></td><td/><td/></tr><tr><td align="right">Exon 3 F</td><td align="left"><monospace>*CAATGTTGCTTTGTGAAT</monospace></td><td align="left">60</td><td align="left">234</td></tr><tr><td align="right">R</td><td align="left"><monospace>TAAAAGCCAGCATCTCGT</monospace></td><td/><td/></tr><tr><td align="right">Exon 4 F</td><td align="left">*CCCCTTGTATCTGGTTTT</td><td align="left">57</td><td align="left">316</td></tr><tr><td align="right">R</td><td align="left">GTCTACTTTATACACGTCCC</td><td/><td/></tr><tr><td align="right">Exon5 F</td><td align="left"><monospace>*ATTGCTGATGTGGGTTGT</monospace></td><td align="left">60</td><td align="left">297</td></tr><tr><td align="right">R</td><td align="left"><monospace>GTTGCCTTTGCCATTTCC</monospace></td><td/><td/></tr><tr><td align="right">Exon 6 F</td><td align="left">*TAGGCAAGTAGCAATAAATAG</td><td align="left">60</td><td align="left">303</td></tr><tr><td align="right">R</td><td align="left">ACATAATGGATTCAGGAAAA</td><td/><td/></tr><tr><td align="right">Exon 7 F</td><td align="left">*GCTCAGCGTTTAAGTGAT</td><td align="left">61</td><td align="left">268</td></tr><tr><td align="right">R</td><td align="left">GCATCGACCTGTCCCTCT</td><td/><td/></tr><tr><td align="right">Exon 8 F</td><td align="left"><monospace>*GGGATTGGAGAATTATCAG</monospace></td><td align="left">60</td><td align="left">299</td></tr><tr><td align="right">R</td><td align="left"><monospace>AGTCTTGGGAGGAGTGGG</monospace></td><td/><td/></tr><tr><td align="right">Exon13 F</td><td align="left">*TTCCTTTCCACTTGACCCC</td><td align="left">60</td><td align="left">391</td></tr><tr><td align="right">R</td><td align="left">AAAACCCTGAGCAGATGCA</td><td/><td/></tr><tr><td align="right">Exon 14-1 F</td><td align="left">*TGTGAGGCAGGCAATGTG</td><td align="left">53</td><td align="left">325</td></tr><tr><td align="right">R</td><td align="left">GGAGAAGCAGGGCGAGAT</td><td/><td/></tr><tr><td align="right">Exon 14-2 F</td><td align="left">*ATCTCGCCCTGCTTCTCC</td><td align="left">55</td><td align="left">489</td></tr><tr><td align="right">R</td><td align="left">GCTGCTGAGGCTGCTGAA</td><td/><td/></tr><tr><td align="right">Exon 14-3 F</td><td align="left">*AGAGGATGAGCCTGAAGACG</td><td align="left">56</td><td align="left">486</td></tr><tr><td align="right">R</td><td align="left">GCTGCTCGTACCCTGCTT</td><td/><td/></tr><tr><td align="right">Exon 14-4 F</td><td align="left">*CTGATGCCAACCTGAACG</td><td align="left">56</td><td align="left">479</td></tr><tr><td align="right">R</td><td align="left">TCCACTGGTGCCACTTCC</td><td/><td/></tr><tr><td align="right">Exon 14-5 F</td><td align="left">*TGGTCGTCCACCCGCAGAA</td><td align="left">58</td><td align="left">490</td></tr><tr><td align="right">R</td><td align="left">GGCCCTTGGTAGATGTTGATGT</td><td/><td/></tr><tr><td align="right">Exon 14-6 F</td><td align="left">*AGATGCTTGGGCAGATTAG</td><td align="left">60</td><td align="left">350</td></tr><tr><td align="right">R</td><td align="left">TGAACCAGCTTTCGTGTC</td><td/><td/></tr><tr><td align="right">Exon 14-7 F</td><td align="left">*CGCTGTGCTCTAATCTGC</td><td align="left">60</td><td align="left">491</td></tr><tr><td align="right">R</td><td align="left">TATTGATTTCCGTTGGTTG</td><td/><td/></tr></tbody></table><table-wrap-foot><p>*GC clamp was added at the 5' end of the forward primers</p><p>GC clamp: cgcccgccgcgccccgcgcccggcccgccgcccccgcccg</p></table-wrap-foot></table-wrap></sec><sec><title>Identification of the rat <italic>Gli3 </italic>promoter</title><p>To obtain a candidate rat <italic>Gli3 </italic>promoter sequence, four forward primers were designed upstream of the rat <italic>Gli3</italic>: Gli3(-1107), 5'-GTG ACC TGC CTG TGC CTG TA-3'; Gli3(-532), 5'-TTA ACC TCT GCG TTA CAA CC-3'; Gli3(-388), 5'-ATC AGA GGG TCT CAG CGT TAG-3'; and Gli3(-128), 5'-CTC CTC AGG CAG AAG ATG CA -3'. Four products were obtained when rat genomic DNA was amplified with each of these primers and the Gli3 reverse primer 5'-ACA CCA CAG TGC CAT CAA A -3'. The amplified fragments were verified by sequencing and cloned into a PMD-18T vector. The clones were digested with <italic>Kpn</italic>I and <italic>Hind</italic>III and cloned into the <italic>Kpn</italic>I and <italic>Hind</italic>III sites of the pGL3-luciferase vector (Promega, USA).</p><p>L6GNR4 rat myoblastocytes (Cell Laboratory, Chinese Academy of Sciences, Shanghai) were cultured in Dulbecco's Modified Eagle's Medium supplemented with 10% fetal calf serum, 100 units/mL penicillin, 100 &#x003bc;g/mL streptomycin and then incubated in 5% CO<sub>2 </sub>at 37&#x000b0;C. L6 cells were transfected using a liposome transfection kit (Invitrogen, USA). In each transfection, 12 &#x003bc;g reporter plasmid and 0.1 &#x003bc;g pRL-TK (internal control for transfection efficiency) were used per 6-cm dish. Cells were incubated for 48 hours at 37&#x000b0;C. After transfection, the cells were washed with PBS, lysed with 1&#x000d7; passive lysis buffer and assayed for luciferase activity using the Dual-Luciferase Reporter Assay System (Promega, USA).</p></sec><sec><title>Analysis of the rat <italic>Gli3 </italic>5' region</title><p>To search for regulatory elements in the <italic>Gli3 </italic>transcriptional control regions, we analyzed the genomic sequence 1000 bp upstream of the transcription start site using P-Match <ext-link ext-link-type="uri" xlink:href="http://www.gene-regulation.com">http://www.gene-regulation.com</ext-link>.</p></sec><sec><title>Chromatin immunoprecipitation assays (ChIP)</title><p>ChIP assays were performed according to the manufacturer's instructions (Active Motif, USA). Hindlimbs of GD14 rats were homogenized in PBS on ice. Hoxd13 antibody (8 &#x003bc;g) (Santa Cruz, USA) was used for the immunoprecipitation, and 8 &#x003bc;g of the Sox9 antibody (Santa Cruz, USA) was used as a negative control. DNA was extracted as recommended by protocol. We used 2.5 &#x003bc;L of each sample as a template for PCR using the following primers:</p><p><italic>Gli3 Site1</italic>: ACACTGAGGGCCCTGGGTAG</p><p><italic>Gli3 Site1 rev</italic>: GTGCCGAAAGGGTTGTAACG</p><p><italic>Gli3 Site2</italic>: AACCCTTTCGGCACACTTCTG</p><p><italic>Gli3 Site2 rev</italic>: GTGGCTCTCAACCTTCCTAACG</p><p>PCR reactions had an initial denaturing step at 94&#x000b0;C for 5 minutes, followed by 35 cycles of denaturing at 94&#x000b0;C for 35 sec, annealing at 59&#x000b0;C for 35 sec and extension at 72&#x000b0;C for 35 sec, and ended with a final extension at 72&#x000b0;C for 10 min.</p></sec><sec><title>Electrophoretic mobility shift assays (EMSA)</title><p>Nucleoprotein was extracted from E14.5 rat embryo limbs using a cytoplasmic and nuclear protein extract kit (Activ Motif, USA) according to the manufacturer's instructions Oligonucleotides and their complementary strands were used to evaluate binding of HoxD13 to the <italic>Gli3 </italic>HoxD13-binding site (5'-<italic>CTAGG</italic>-3'). The double-stranded wild-type (tttaca<italic>CTAGG</italic>attcataaccatagcataattacagcta) and mutated (tttaca<italic>GCTAA</italic>attcataaccatagcataattacagcta) sequences were labeled with biotin according to standard protocols (Pierce, USA). A 100-fold excess of unlabeled probe was used as a specific competitor. The DNA-binding ability of the different proteins was monitored by EMSA on a 10% non-denaturing polyacrylamide gel. DNA binding bands were detected using a chemiluminescence system (Pierce, USA).</p></sec></sec><sec><title>Results</title><sec><title><italic>Gli3 </italic>is not expressed in the flexor hallucis longus of ICTEV patients</title><p>To investigate the expression profiles of <italic>Gli3 </italic>in flexor hallucis longus, Semi-quantitative RT-PCR was performed using total RNA from the flexor hallucis longus of patients and cadavers as well as the lung tissues of cadavers. No <italic>Gli3 </italic>expression was detected in the flexor hallucis longus; however, expression was detected in control lung tissue (Fig. <xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Semi-quantitative RT-PCR analysis of <italic>Gli3 </italic>mRNA expression in flexor hallucis longus and lung tissue</bold>. <italic>Gli3 </italic>expression was not found in the flexor hallucis longus. Lanes 1 is an RT-PCR sample from an ICTEV patient flexor hallucis longus, lane 2 is a normal control flexor hallucis longus RT-PCR and lane 3 is a normal control lung RT-PCR. <italic>&#x003b2;-actin </italic>expression is shown as a control for all samples. Lane M is a size marker.</p></caption><graphic xlink:href="1471-2474-10-142-1"/></fig></sec><sec><title>Identification of rat ICTEV model</title><p>The embryos were harvested from ATRA-treated pregnant rats at GD15, 17, 19 and 21. We found embryos with clubfoot at GD15. A comparison between ICTEV and normal embryos at GD 21 is shown in Fig <xref ref-type="fig" rid="F2">2</xref>. Hind limb abnormality was observed in embryos of the ICTEV model rat, similar to that seen in ICTEV patients. A total of 74 embryos with clubfoot were found out of 245 embryos (30.2%), indicating that the ICTEV model was successfully established.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>Comparison of ICTEV and normal embryos at GD21</bold>. (A) Foot of an ICTEV patient, showing cavus, adductus, varus and equines. (B) The hindlimbs of normal embryos at GD21 presented with normal development. (C) The hindlimbs of ICTEV embryos at GD21 presented with dysplasia of the foot, showing cavus and adductus as observed in ICTEV patients.</p></caption><graphic xlink:href="1471-2474-10-142-2"/></fig></sec><sec><title>ICTEV association with <italic>Gli3 </italic>is not due to genetic mutations</title><p>Unlike other disorders associated with <italic>Gli3</italic>, no mutations were observed in the 5' flanking sequence or in <italic>Gli3 </italic>exons 1-8, 13 and 14 in the ICTEV patients.</p></sec><sec><title>Gli3 has higher expression in ICTEV model rats than in control rats</title><p>To study <italic>Gli3 </italic>earlier in development, we used a rat model for ICTEV. Expression of <italic>Gli3 </italic>was higher in ICTEV model rat embryonic hindlimbs compared to normal control rat embryonic hindlimbs (Fig. <xref ref-type="fig" rid="F3">3</xref>). Similarly, Gli3 protein showed increased abundance in ICTEV model rat embryonic hindlimbs compared to normal control rat embryos (Fig. <xref ref-type="fig" rid="F4">4</xref>). For both ICTEV model rats and normal control rats, <italic>Gli3 </italic>RNA levels and Gli3 protein abundance decreased during embryonic development (Figs. <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref>). Using immunohistochemistry, the Gli3 protein in ICTEV rats was localized to the foot muscle of the rats (Fig. <xref ref-type="fig" rid="F5">5</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Real-time PCR analysis of <italic>Gli3 </italic>expression in the hindlimb of ICTEV model rat and normal control rat embryos</bold>. Compared to the normal control, <italic>Gli3 </italic>mRNA expression was significantly enhanced. With birth drawing near, <italic>Gli3 </italic>expression in both model and normal rats had the tendency to decrease. Column 1, 3, 5 and 7 show <italic>Gli3 </italic>relative expression in ICTEV model rat at GD15, GD17, GD19 and GD21, respectively. Column 2, 4, 6 and 8 show <italic>Gli3 </italic>relative expression in normal control rat embryos at GD15, GD17, GD19 and GD21, respectively.</p></caption><graphic xlink:href="1471-2474-10-142-3"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>Western blot results</bold>. Western blots were used to determine Gli3 protein abundance in nuclear extracts from the hindlimb tissue of ICTEV model rat and normal control rat embryos. Compared to the normal control, <italic>Gli3 </italic>expression was significantly enhanced in model rats. With birth drawing near, <italic>Gli3 </italic>protein expression in both model and normal rats had a tendency to decrease. Lane 1 is the protein of ICTEV model rat embryos at GD15, lane 2 is the protein of normal rat embryos at GD15, lane 3 is the protein of ICTEV model rat embryos at GD17 and lane 4 is the protein of normal rat embryos at GD17.</p></caption><graphic xlink:href="1471-2474-10-142-4"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>Immunohistochemistry results</bold>. Immunohistochemistry revealed that Gli3 expression in the hindlimb tissue of ICTEV model rat embryos was higher than that in normal control rat embryos at GD19 (400&#x000d7;). (A) Hindlimb tissue of a normal control rat embryo labeled with PBS. (B) Hindlimb tissue of an ICTEV model rat embryo labeled with Gli3 antibody. (C) Hindlimb tissue of a normal control rat embryo labeled with Gli3 antibody.</p></caption><graphic xlink:href="1471-2474-10-142-5"/></fig></sec><sec><title><italic>Gli3 </italic>promoter identification</title><p>To determine the promoter region of <italic>Gli3</italic>, we generated four luciferase reporter constructs (Luc1107, Luc532, Luc388 and Luc128) with fragments upstream of <italic>Gli3 </italic>as the promoters. All the luciferase reporter constructs showed higher promoter activity compared to the pGL3-basic reporter vector. Relative to the pGL3-basic reporter vector, Luc128, Luc388, Luc532 and Luc1107 increased luciferase activity 2-fold, 20-fold, 8-fold and 53-fold, respectively (Fig. <xref ref-type="fig" rid="F6">6</xref>). These data suggest that there are positive regulatory elements in the regions from -1107 to -532, -388 to -128 and from -128 to -48 upstream of <italic>Gli3 </italic>and negative regulatory elements in the region from -532 to -388 upstream of <italic>Gli3</italic>.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Relative activities of rat Gli3 promoter regions in a luciferase reporter construct</bold>. Activities were measured in L6 cells. Findings suggested positive regulatory elements existed in the regions from -1107 to -532, -388 to -128 and from -128 to -48 upstream of <italic>Gli3 </italic>and negative regulatory elements in the region from -532 to -388 upstream of <italic>Gli3</italic>.</p></caption><graphic xlink:href="1471-2474-10-142-6"/></fig></sec><sec><title>HoxD13 binding sites in the 5' region of the rat <italic>Gli3</italic></title><p>To identify the transcription factors that directly regulate <italic>Gli3 </italic>expression, we analyzed the genomic region upstream of the transcription start site of the <italic>Gli3 </italic>gene with the transcription binding-site prediction program P-Match. Two putative HoxD13 binding sites, the HoxD13 binding site 1 (-667): <bold><italic>gttct </italic></bold>and the HoxD13 binding site 2 (-477):<bold><italic>ctagg </italic></bold>were identified, suggesting that Hoxd13 could directly bind to these sites to regulate <italic>Gli3 </italic>expression (Fig. <xref ref-type="fig" rid="F7">7</xref>).</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>Potential binding sites</bold>. The rat <italic>Gli3 </italic>proximal promoter region contains two potential HoxD13 binding sites (gray boxes). The transcription start site is indicated by an arrow. The <italic>Gli3 </italic>protein translation start site (ATG) is indicated.</p></caption><graphic xlink:href="1471-2474-10-142-7"/></fig><p>To verify the <italic>in vivo </italic>binding of Hoxd13 to the <italic>Gli3 </italic>promoter, we used ChIP. Cross-linked and sheared chromatin from rat GD14 embryonic hindlimbs were immunoprecipitated with an anti-Hoxd13 antibody and analyzed by PCR. These ChIP analyses revealed that, <italic>in vivo</italic>, Hoxd13 efficiently bound only to binding site 2 (Fig. <xref ref-type="fig" rid="F8">8</xref>). Additionally, nucleoprotein containing Hoxd13 was incubated with a fragment of -483 ~ -446 bp upstream of Gli3 containing site 2. As shown in Fig. <xref ref-type="fig" rid="F9">9</xref>, strong DNA binding was observed in the presence of the Hoxd13 protein. A competition experiment and supershift existence in the presence of the Hoxd13 antibody demonstrated the specificity of such binding. The result indicated Hoxd13 is bound to site 2 in vitro.</p><fig id="F8" position="float"><label>Figure 8</label><caption><p><bold>ChIP results</bold>. The ChIP assay of putative HoxD13 binding sites 1 and 2 in the <italic>Gli3 </italic>promoter. Only HoxD13 binding site 2 binds HoxD13 <italic>in vivo</italic>. In lanes 1 and 5, chromatin from rat embryonic hindlimbs was immunoprecipitated with the HoxD13 antibody. In lanes 2 and 6, the Sox9 antibody was used as a negative control. Lanes 3 and 7 show the enzymatic shearing before immunoprecipitation. Genomic DNA was used as a positive control (lanes 4 and 8). Lane M is a size marker.</p></caption><graphic xlink:href="1471-2474-10-142-8"/></fig><fig id="F9" position="float"><label>Figure 9</label><caption><p><bold>EMSA results</bold>. Electrophoretic mobility shift assay (EMSA) using oligonucleotide probes containing the HoxD13 binding site 2. The *** denotes unbound biotin-labeled DNA, ** denotes Hoxd13-DNA complexes and * denotes Hoxd13-antibody-Hoxd13-DNA complexes.</p></caption><graphic xlink:href="1471-2474-10-142-9"/></fig></sec></sec><sec><title>Discussion</title><p>The mammalian <italic>Gli </italic>gene family encodes zinc finger transcription factors and plays a role in developmental regulation and human diseases [<xref ref-type="bibr" rid="B34">34</xref>]. One member of this family, <italic>Gli3</italic>, was identified as a candidate gene for ICTEV [<xref ref-type="bibr" rid="B26">26</xref>]. To investigate the mechanism of this association, we investigated Gli3 mRNA and protein expression patterns in ICTEV patients. <italic>Gli3 </italic>was not expressed in the flexor hallucis longus of ICTEV patients, suggesting that although <italic>Gli3 </italic>is important for correct limb development, it is no longer expressed in postnatal limbs.</p><p>To investigate the role of <italic>Gli3 </italic>role in ICTEV earlier in development, we established an ICTEV rat model and detected <italic>Gli3 </italic>expression in rat embryonic hindlimbs. There are some concerns regarding the rat model of ICTEV induced with ATRA in pregnant rats. The rat model has some limitations. After induction with ATRA, not all fetal rats were exhibited with symptoms of ICTEV. Those that developed the clubfoot also developed malformations such as rima oculi, spina bifida, cranial deformation and anal atresia. Although the rat model of ICTEV induced with ATRA is not ideal and is controversial, it is currently the best rat model of ICTEV. We tested different dosages of ATRA in preliminary experiments and found that 135 mg/kg was the dose at which the highest percentage (about 30%) of clubfeet in the lower limbs was achieved. We only selected the fetal rats with clubfeet as the experimental subjects to ensure the most legitimate comparison to patients with ICTEV. We found that both Gli3 mRNA and protein expression levels were higher in the ICTEV model rats compared to normal control rats. Furthermore, with birth drawing near, the <italic>Gli3 </italic>gene expression in both of the normal control group and the model group was gradually downregulated (Figs. <xref ref-type="fig" rid="F3">3</xref> and <xref ref-type="fig" rid="F4">4</xref>), indicating that the <italic>Gli3 </italic>gene is a very important gene in regulating the limb development and that its role of regulating limb development may disappear after birth. This is also consistent the inability to detect the <italic>Gli3 </italic>gene in the flexor hallucis longus of adults (Fig. <xref ref-type="fig" rid="F1">1</xref>), which may be because it is not expressed in the lower limb post-birth. The occurrence of ICTEV may be caused by changes in the expression level of this critical gene that is related to limb development. Immunohistochemical results suggest that <italic>Gli3 </italic>protein expression in the muscles around ankles of model fetal rats was remarkably higher than in the control group, and the affected sites of patients with ICTEV were also in the ankle. The location of this muscle was identical to that of flexor hallucis longus; therefore, it is reasonable to conclude that the occurrence of ICTEV is associated with changes in the expression level of <italic>Gli3</italic>. To identify the underlying reason for the change in <italic>Gli3 </italic>expression, we first looked for mutations in the <italic>GLI3 </italic>promoter and coding regions of ICTEV patients. A previous study investigating mutations in <italic>GLI3 </italic>exons 9, 10, 11 and 12 identified only one polymorphism [<xref ref-type="bibr" rid="B26">26</xref>]. To complete this study, we sequenced the remaining exons and the promotor, but did not detect any polymorphisms. While a larger sample size might reveal polymorphisms, these data suggest that the <italic>Gli3 </italic>mutation is not the root of its association with ICTEV.</p><p>The changes in <italic>Gli3 </italic>gene expression may be caused by changes in some transcription factors that regulate the <italic>GLI3 </italic>gene, ultimately leading to the development of ICTEV. Accordingly, future studies should focus on the regulation of the <italic>GLI3 </italic>gene and its function.</p><p>Alternatively, <italic>Gli3 </italic>could be differentially regulated in ICTEV model rat embryos compared to normal control embryos. To determine the transcription factors that bind to the promoter region of <italic>Gli3</italic>, we constructed a series of rat <italic>Gli3 </italic>truncated promoters and cloned them into reporter gene constructs. These analyses suggested that the promoter has both positive and negative regulatory elements. Putative HoxD13 binding sites 1 and 2 in <italic>Gli3</italic>'s upstream 5' region were located in positive and negative regulatory elements, respectively. HoxD13, however, only bound to site 2 <italic>in vivo</italic>. <italic>In vitro </italic>competition experiments also revealed a specific affinity of Hoxd13 to this site. Thus, Hoxd13 can directly regulate the expression of <italic>Gli3 </italic>during limb formation. We cannot, however, exclude the possibility that Hoxd13 interacts with the <italic>Gli3 </italic>promoter regions as a part of a protein complex. In ICTEV patients, <italic>HOXD13 </italic>has lower expression compared to healthy subjects [<xref ref-type="bibr" rid="B27">27</xref>]. Thus, the decrease in <italic>HOXD13 </italic>expression maybe led to a change in the expression of <italic>GLI3</italic>, which manifests as ICTEV.</p><p>This study provides a theoretical basis for the pathogenesis of ICTEV. Future studies will investigate how <italic>HoxD13 </italic>regulates <italic>Gli3 </italic>during limb development and will provide a clearer mechanism for the pathogenesis of ICTEV.</p></sec><sec><title>Conclusion</title><p>Our study indicates that HoxD13 directly interacts with the promoter of <italic>Gli3 </italic>and Gli3 mRNA and protein expression levels were increased in the ICTEV model rats. These findings suggest that HoxD13 is a transcription factor of <italic>Gli3</italic>. Low expression of <italic>HOXD13 </italic>might lead to increase GLI3 expression level during limb formation, which likely plays a key role in ICTEV pathogenesis.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>DHC is the guarantor of the study. He designed the study and was the primary writer of the manuscript. MHR and CKL designed and wrote the study and critically revised the study for its content. XZ and NZ initiated and monitored the study. CLJ supervised and critically revised the study for its content. All authors read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/10/142/prepub">http://www.biomedcentral.com/1471-2474/10/142/prepub</ext-link></p></sec></body><back><sec><title>Acknowledgements</title><p>This study was supported by a grant from the National Key Research Project of China (No. 30973140).</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Dietz</surname><given-names>FMD</given-names></name><article-title>The genetics of idiopathic clubfoot</article-title><source>Clin Orthop Relat Res</source><year>2002</year><volume>401</volume><fpage>39</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1097/00003086-200208000-00007</pub-id><pub-id pub-id-type="pmid">12151881</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Cardy</surname><given-names>AH</given-names></name><name><surname>Barker</surname><given-names>S</given-names></name><name><surname>Chesney</surname><given-names>D</given-names></name><name><surname>Sharp</surname><given-names>L</given-names></name><name><surname>Maffulli</surname><given-names>N</given-names></name><name><surname>Miedzybrodzka</surname><given-names>Z</given-names></name><article-title>Pedigree analysis and epidemiological features of idiopathic congenital talipes equinovarus in the United Kingdom: a case-control study</article-title><source>BMC Musculoskelet Disord</source><year>2007</year><volume>8</volume><fpage>62</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-8-62</pub-id><pub-id pub-id-type="pmid">17610748</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Rebbeck</surname><given-names>TR</given-names></name><name><surname>Dietz</surname><given-names>FR</given-names></name><name><surname>Murray</surname><given-names>JC</given-names></name><name><surname>Buetow</surname><given-names>KH</given-names></name><article-title>A single gene explanation for the probability of having idiopathic talipes equinovarus</article-title><source>Am J Hum Genet</source><year>1993</year><volume>53</volume><fpage>1051</fpage><lpage>1063</lpage><pub-id pub-id-type="pmid">8213831</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Wynne-Davies</surname><given-names>R</given-names></name><article-title>Genetic and environmental factors in the etiology of talipes equinovarus</article-title><source>Clin Orthop</source><year>1972</year><volume>84</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1097/00003086-197205000-00003</pub-id><pub-id pub-id-type="pmid">5032855</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Chapman</surname><given-names>C</given-names></name><name><surname>Stott</surname><given-names>NS</given-names></name><name><surname>Port</surname><given-names>RV</given-names></name><name><surname>Nicol</surname><given-names>RO</given-names></name><article-title>Genetics of clubfoot in Maori and Pacific people</article-title><source>J Med Genet</source><year>2000</year><volume>37</volume><fpage>680</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.1136/jmg.37.9.680</pub-id><pub-id pub-id-type="pmid">10978359</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Miedzybrodzka</surname><given-names>Z</given-names></name><article-title>Congenital talipes equinovarus (clubfoot): a disorder of the foot but not the hand</article-title><source>J Anat</source><year>2003</year><volume>202</volume><fpage>37</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1046/j.1469-7580.2003.00147.x</pub-id><pub-id pub-id-type="pmid">12587918</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Capdevila</surname><given-names>J</given-names></name><name><surname>Izpis&#x000fa;a Belmonte</surname><given-names>JC</given-names></name><article-title>Patterning mechanisms controlling vertebrate limb development</article-title><source>Annu Rev Cell Dev Biol</source><year>2001</year><volume>17</volume><fpage>87</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.17.1.87</pub-id><pub-id pub-id-type="pmid">11687485</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Riddle</surname><given-names>RD</given-names></name><name><surname>Johnson</surname><given-names>RL</given-names></name><name><surname>Laufer</surname><given-names>E</given-names></name><name><surname>Tabin</surname><given-names>C</given-names></name><article-title>Sonic hedgehog mediates the polarizing activity of the ZPA</article-title><source>Cell</source><year>1993</year><volume>75</volume><fpage>1401</fpage><lpage>1416</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90626-2</pub-id><pub-id pub-id-type="pmid">8269518</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Weed</surname><given-names>M</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><name><surname>Olsen</surname><given-names>BR</given-names></name><article-title>The Role of Sonic Hedgehog in Vertebrate Development</article-title><source>Matrix Biology</source><year>1997</year><volume>16</volume><fpage>53</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/S0945-053X(97)90072-X</pub-id><pub-id pub-id-type="pmid">9205942</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Scherz</surname><given-names>PJ</given-names></name><name><surname>McGlinn</surname><given-names>E</given-names></name><name><surname>Nissim</surname><given-names>S</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name><article-title>Extended exposure to Sonic hedgehog is required for patterning the posterior digits of the vertebrate limb</article-title><source>Dev Biol</source><year>2007</year><volume>15, 308</volume><fpage>343</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.05.030</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Altaba</surname><given-names>ARI</given-names></name><article-title>Gli proteins encode context-dependent positive and negative functions: implications for development and disease</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>3205</fpage><lpage>3216</lpage><pub-id pub-id-type="pmid">10375510</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>SH</given-names></name><name><surname>Kogerman</surname><given-names>P</given-names></name><name><surname>Lindstr&#x000f6;m</surname><given-names>E</given-names></name><name><surname>Toftg&#x000e1;rd</surname><given-names>R</given-names></name><name><surname>Biesecker</surname><given-names>LG</given-names></name><article-title>GLI3 mutations in human disorders mimic Drosophila Cubitus interruptus protein functions and localization</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>2880</fpage><lpage>2884</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.6.2880</pub-id><pub-id pub-id-type="pmid">10077605</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Dai</surname><given-names>P</given-names></name><name><surname>Akimaru</surname><given-names>H</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Maekawa</surname><given-names>T</given-names></name><name><surname>Nakafuku</surname><given-names>M</given-names></name><name><surname>Ishii</surname><given-names>S</given-names></name><article-title>Sonic hedgehog-induced activation of the Gli1 promoter is mediated by GLI3</article-title><source>Biol Chem</source><year>1999</year><volume>274</volume><fpage>8143</fpage><lpage>8152</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.12.8143</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>HL</given-names></name><name><surname>Bai</surname><given-names>C</given-names></name><name><surname>Platt</surname><given-names>KA</given-names></name><name><surname>Matise</surname><given-names>MP</given-names></name><name><surname>Beeghly</surname><given-names>A</given-names></name><name><surname>Hui</surname><given-names>CC</given-names></name><name><surname>Nakashima</surname><given-names>M</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name><article-title>Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>1593</fpage><lpage>1605</lpage><pub-id pub-id-type="pmid">10725236</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Bai</surname><given-names>C Brian</given-names></name><name><surname>Auerbach</surname><given-names>Wojtek</given-names></name><name><surname>Lee</surname><given-names>Joon S</given-names></name><name><surname>Stephen</surname><given-names>Daniel</given-names></name><name><surname>Alexandra</surname><given-names>L</given-names></name><article-title>Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>4753</fpage><lpage>4761</lpage><pub-id pub-id-type="doi">10.1242/dev.00115</pub-id><pub-id pub-id-type="pmid">12361967</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Ahn</surname><given-names>S</given-names></name><name><surname>Joyner</surname><given-names>AL</given-names></name><article-title>Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.07.023</pub-id><pub-id pub-id-type="pmid">15315762</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Bastida</surname><given-names>MF</given-names></name><name><surname>Delgado</surname><given-names>MD</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Fallon</surname><given-names>JF</given-names></name><name><surname>Fernandez-Teran</surname><given-names>M</given-names></name><name><surname>Ros</surname><given-names>MA</given-names></name><article-title>Levels of Gli3 repressor correlate with Bmp4 expression and apoptosis during limb development</article-title><source>Dev Dyn</source><year>2004</year><volume>231</volume><issue>1</issue><fpage>148</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20121</pub-id><pub-id pub-id-type="pmid">15305295</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Albrecht</surname><given-names>AN</given-names></name><name><surname>Kornak</surname><given-names>U</given-names></name><name><surname>B&#x000f6;ddrich</surname><given-names>A</given-names></name><name><surname>S&#x000fc;ring</surname><given-names>K</given-names></name><name><surname>Robinson</surname><given-names>PN</given-names></name><name><surname>Stiege</surname><given-names>AC</given-names></name><name><surname>Lurz</surname><given-names>R</given-names></name><name><surname>Stricker</surname><given-names>S</given-names></name><name><surname>Wanker</surname><given-names>EE</given-names></name><name><surname>Mundlos</surname><given-names>S</given-names></name><article-title>A molecular pathogenesis for transcription factor associated poly-alanine tract expansions</article-title><source>Hum Mol Genet</source><year>2004</year><volume>13</volume><fpage>2351</fpage><lpage>2359</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddh277</pub-id><pub-id pub-id-type="pmid">15333588</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>D'Esposito</surname><given-names>M</given-names></name><name><surname>Morelli</surname><given-names>F</given-names></name><name><surname>Acampora</surname><given-names>D</given-names></name><name><surname>Migliaccio</surname><given-names>E</given-names></name><name><surname>Simeone</surname><given-names>A</given-names></name><name><surname>Boncinelli</surname><given-names>E</given-names></name><article-title>EVX2, a human homeobox gene homologous to the even-skipped segmentation gene, is localized at the 5-prime end of HOX4 locus on chromosome 2</article-title><source>Genomics</source><year>1991</year><volume>10</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/0888-7543(91)90482-T</pub-id><pub-id pub-id-type="pmid">1675198</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Witte</surname><given-names>DP</given-names></name><name><surname>Hsieh-Li</surname><given-names>HM</given-names></name><name><surname>Potter</surname><given-names>SS</given-names></name><name><surname>Capecchi</surname><given-names>MR</given-names></name><article-title>Absence of radius and ulna in lacking Hoxa-11 and Hoxd-11</article-title><source>Nature</source><year>1995</year><volume>375</volume><fpage>791</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1038/375791a0</pub-id><pub-id pub-id-type="pmid">7596412</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Knezevic</surname><given-names>V</given-names></name><name><surname>Ervin</surname><given-names>V</given-names></name><name><surname>Hutson</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>Y</given-names></name><name><surname>Mackem</surname><given-names>S</given-names></name><article-title>Direct interaction with Hoxd proteins reverses Gli3-repressor function to promote digit formation downstream of Shh</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>2339</fpage><lpage>2347</lpage><pub-id pub-id-type="doi">10.1242/dev.01115</pub-id><pub-id pub-id-type="pmid">15102708</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Vortkamp</surname><given-names>A</given-names></name><name><surname>Gessler</surname><given-names>M</given-names></name><name><surname>Grzeschik</surname><given-names>K-H</given-names></name><article-title>GLI3 zinc-finger gene interrupted by translocations in Greig syndrome families</article-title><source>Nature</source><year>1991</year><volume>352</volume><fpage>539</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1038/352539a0</pub-id><pub-id pub-id-type="pmid">1650914</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Graham</surname><given-names>JM</given-names><suffix>Jr</suffix></name><name><surname>Olney</surname><given-names>AH</given-names></name><name><surname>Biesecker</surname><given-names>LG</given-names></name><article-title>GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome</article-title><source>Nat Genet</source><year>1997</year><volume>15</volume><fpage>266</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1038/ng0397-266</pub-id><pub-id pub-id-type="pmid">9054938</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Radhakrishna</surname><given-names>U</given-names></name><name><surname>Wild</surname><given-names>A</given-names></name><name><surname>Grzeschik</surname><given-names>KH</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><article-title>Mutation in GLI3 in postaxial polydactyly type A</article-title><source>Nat Genet</source><year>1997</year><volume>17</volume><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1038/ng1197-269</pub-id><pub-id pub-id-type="pmid">9354785</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Radhakrishna</surname><given-names>U</given-names></name><name><surname>Bornholdt</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>HS</given-names></name><name><surname>Patel</surname><given-names>UC</given-names></name><name><surname>Rossier</surname><given-names>C</given-names></name><name><surname>Engel</surname><given-names>H</given-names></name><name><surname>Bottani</surname><given-names>A</given-names></name><name><surname>Chandal</surname><given-names>D</given-names></name><name><surname>Blouin</surname><given-names>JL</given-names></name><name><surname>Solanki</surname><given-names>JV</given-names></name><name><surname>Grzeschik</surname><given-names>KH</given-names></name><name><surname>Antonarakis</surname><given-names>SE</given-names></name><article-title>The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; no phenotype prediction from the position of GLI3 mutations</article-title><source>Am J Hum Genet</source><year>1999</year><volume>65</volume><fpage>645</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1086/302557</pub-id><pub-id pub-id-type="pmid">10441570</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>CL</given-names></name><name><surname>Liu</surname><given-names>LY</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>LJ</given-names></name><name><surname>Ji</surname><given-names>SJ</given-names></name><name><surname>Sun</surname><given-names>KL</given-names></name><article-title>Association and mutation analysis of GLI3 gene in idiopathic congenital talipes equinovarus</article-title><source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source><year>2006</year><volume>23</volume><fpage>551</fpage><lpage>554</lpage><pub-id pub-id-type="pmid">17029207</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Jin</surname><given-names>CL</given-names></name><name><surname>Liu</surname><given-names>LY</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ji</surname><given-names>SJ</given-names></name><name><surname>Sun</surname><given-names>KL</given-names></name><article-title>Analysis of association between 5' HOXD gene and idiopathic congenital talipes equinovarus</article-title><source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source><year>2005</year><volume>22</volume><fpage>653</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">16331564</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Fu</surname><given-names>WN</given-names></name><name><surname>Li-Ling</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>ZG</given-names></name><name><surname>Li</surname><given-names>LY</given-names></name><name><surname>Sun</surname><given-names>KL</given-names></name><article-title>HOXD13 may play a role in idiopathic congenital clubfoot by regulating the expression of FHL1</article-title><source>Cytogenet Genome Res</source><year>2008</year><volume>121</volume><issue>3-4</issue><fpage>189</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1159/000138884</pub-id><pub-id pub-id-type="pmid">18758158</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Delgado Baeza</surname><given-names>E</given-names></name><name><surname>Santos Alvarez</surname><given-names>I</given-names></name><name><surname>Martos Rodriguez</surname><given-names>A</given-names></name><article-title>Retinoic acid induced clubfoot like deformity: pathoanatomy in rat embryos</article-title><source>J Pediatr Orthop B</source><year>1999</year><volume>8</volume><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1097/00009957-199901000-00003</pub-id><pub-id pub-id-type="pmid">10709591</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>ZG</given-names></name><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>WN</given-names></name><name><surname>Zhao</surname><given-names>YY</given-names></name><name><surname>Jin</surname><given-names>CL</given-names></name><name><surname>Ji</surname><given-names>SJ</given-names></name><name><surname>Sun</surname><given-names>KL</given-names></name><article-title>Proteomic analysis of the ankle joint bone, ankle joint tissue and spinal cord of clubfoot-like deformity in rat fetuses</article-title><source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source><year>2007</year><volume>24</volume><issue>1</issue><fpage>52</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17285545</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Ruppert</surname><given-names>JM</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Wong</surname><given-names>AJ</given-names></name><name><surname>Bigner</surname><given-names>SH</given-names></name><name><surname>Kao</surname><given-names>F-T</given-names></name><name><surname>Law</surname><given-names>ML</given-names></name><name><surname>Seuanez</surname><given-names>HN</given-names></name><name><surname>O'brien</surname><given-names>SJ</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><article-title>The GLI-Kruppel family of human genes</article-title><source>Molec Cell Biol</source><year>1988</year><volume>8</volume><fpage>3104</fpage><lpage>3113</lpage><pub-id pub-id-type="pmid">2850480</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Kalb</surname><given-names>VF</given-names><suffix>Jr</suffix></name><name><surname>Bernlohr</surname><given-names>RW</given-names></name><article-title>A new spectrophotometric assay for protein in cell extracts</article-title><source>Anal Biochem</source><year>1977</year><volume>82</volume><fpage>362</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(77)90173-7</pub-id><pub-id pub-id-type="pmid">20815</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Hout</surname><given-names>AH van der</given-names></name><name><surname>Ouweland</surname><given-names>AM van den</given-names></name><name><surname>Luijt</surname><given-names>RB van der</given-names></name><name><surname>Gille</surname><given-names>HJ</given-names></name><name><surname>Bodmer</surname><given-names>D</given-names></name><name><surname>Br&#x000fc;ggenwirth</surname><given-names>H</given-names></name><name><surname>Mulder</surname><given-names>IM</given-names></name><name><surname>Vlies</surname><given-names>P van der</given-names></name><name><surname>Elfferich</surname><given-names>P</given-names></name><name><surname>Huisman</surname><given-names>MT</given-names></name><name><surname>ten Berge</surname><given-names>AM</given-names></name><name><surname>Kromosoeto</surname><given-names>J</given-names></name><name><surname>Jansen</surname><given-names>RP</given-names></name><name><surname>van Zon</surname><given-names>PH</given-names></name><name><surname>Vriesman</surname><given-names>T</given-names></name><name><surname>Arts</surname><given-names>N</given-names></name><name><surname>Lange</surname><given-names>MB</given-names></name><name><surname>Oosterwijk</surname><given-names>JC</given-names></name><name><surname>Meijers-Heijboer</surname><given-names>H</given-names></name><name><surname>Ausems</surname><given-names>MG</given-names></name><name><surname>Hoogerbrugge</surname><given-names>N</given-names></name><name><surname>Verhoef</surname><given-names>S</given-names></name><name><surname>Halley</surname><given-names>DJ</given-names></name><name><surname>Vos</surname><given-names>YJ</given-names></name><name><surname>Hogervorst</surname><given-names>F</given-names></name><name><surname>Ligtenberg</surname><given-names>M</given-names></name><name><surname>Hofstra</surname><given-names>RM</given-names></name><article-title>A DGGE system for comprehensive mutation screening of BRCA1 and BRCA2: application in a Dutch cancer clinic setting</article-title><source>Hum Mutat</source><year>2006</year><volume>27</volume><fpage>654</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1002/humu.20340</pub-id><pub-id pub-id-type="pmid">16683254</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Choi</surname><given-names>SC</given-names></name><name><surname>Litingtung</surname><given-names>Y</given-names></name><name><surname>Chiang</surname><given-names>C</given-names></name><article-title>Sonic hedgehog signaling regulates Gli3 processing, mesenchymal proliferation, and differentiation during mouse lung organogenesis</article-title><source>Developmental Biology</source><year>2004</year><volume>270</volume><fpage>214</fpage><lpage>231</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2004.03.009</pub-id><pub-id pub-id-type="pmid">15136151</pub-id></mixed-citation></ref></ref-list></back></article>